# Abbreviations and Acronyms

| Abbreviation | Definition |
|-------------|-----------|
| ADCC | Antibody-dependent cellular cytotoxicity |
| AML | Acute myeloid leukemia |
| ATCC | American Type Culture Collection |
| BCA | Bicinchoninic acid (protein assay) |
| Bcl-xL | B-cell lymphoma-extra large (anti-apoptotic protein) |
| BALB/c | Inbred mouse strain used for CT26 syngeneic model |
| CBD | Cannabidiol |
| CCL5 | C-C motif chemokine ligand 5 (RANTES) |
| CD8+ | Cytotoxic T lymphocyte surface marker |
| cGAS | Cyclic GMP-AMP synthase (innate immune DNA sensor) |
| CI | Combination index (Chou-Talalay pharmacology) |
| CL | Cardiolipin (inner mitochondrial membrane phospholipid) |
| CoQ10 | Coenzyme Q10 (ubiquinone) |
| CRC | Colorectal cancer |
| CTLA-4 | Cytotoxic T-lymphocyte-associated protein 4 (immune checkpoint) |
| CT26 | Murine colorectal carcinoma cell line |
| CXCL10 | C-X-C motif chemokine ligand 10 (IP-10) |
| DRI | Dose-reduction index |
| EC50 | Half-maximal effective concentration |
| EGS | Ethylene glycol bis-succinimidyl succinate (chemical cross-linker) |
| ELISA | Enzyme-linked immunosorbent assay |
| ESMO | European Society for Medical Oncology |
| FBS | Fetal bovine serum |
| FDA | U.S. Food and Drug Administration |
| GJS | Gate-Jamming Score (mathematical model, this work) |
| HCC | Hepatocellular carcinoma (liver cancer) |
| HCT116 | Human MSS colorectal carcinoma cell line |
| HK-II | Hexokinase II (glycolytic enzyme and VDAC1 binding partner) |
| HMG-CoA | 3-Hydroxy-3-methylglutaryl coenzyme A |
| IACUC | Institutional Animal Care and Use Committee |
| ICI | Immune checkpoint inhibitor |
| IFN-B | Interferon beta (innate immune signaling cytokine) |
| MSI-H | Microsatellite instability-high |
| MSS | Microsatellite stable |
| mtDNA | Mitochondrial DNA |
| MbCD | Methyl-beta-cyclodextrin (cholesterol-depleting agent) |
| NK | Natural killer cell |
| OMM | Outer mitochondrial membrane |
| ORR | Objective response rate |
| OSF | Open Science Framework |
| PD-1 | Programmed death-1 (immune checkpoint receptor) |
| PD-L1 | Programmed death-ligand 1 |
| PK11195 | TSPO ligand / antagonist used in Experiment 5 |
| qPCR | Quantitative polymerase chain reaction |
| ROS | Reactive oxygen species |
| SAD | Strategic Architecture Document |
| SDS-PAGE | Sodium dodecyl sulfate-polyacrylamide gel electrophoresis |
| SEM | Standard error of the mean |
| siRNA | Small interfering RNA (gene knockdown tool) |
| STING | Stimulator of interferon genes |
| TCGA | The Cancer Genome Atlas |
| TME | Tumor microenvironment |
| TNBC | Triple-negative breast cancer |
| Treg | Regulatory T cell |
| TSPO | Translocator protein 18 kDa |
| VDAC1 | Voltage-dependent anion channel 1 |
